Breaking News

Modernizing Biopharmaceutical Sampling

July 31, 2014

Funded so far by Pfizer and Lilly, Bend Research is beta testing the Modular Automated Sampling Technology platform, that would bring process analytical technology (PAT) to biopharmaceutical development and manufacturing

Bend Research and pharmaceutical company partners are currently beta testing MAST, a modular automated sampling technology platform designed to allow for hands-off and contamination-free sampling from up to 8 bioreactors at a time.  The platform has also been designed to enable at-line analysis, automated scheduling and other benefits.  For more information, click here. 

blog comments powered by Disqus